
Spectral Medical Inc
TSX:EDT

Intrinsic Value
The intrinsic value of one
EDT
stock under the Base Case scenario is
0.04
CAD.
Compared to the current market price of 1.1 CAD,
Spectral Medical Inc
is
Overvalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Spectral Medical Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Spectral Medical Inc
Balance Sheet Decomposition
Spectral Medical Inc
Current Assets | 3.3m |
Cash & Short-Term Investments | 1.7m |
Receivables | 310k |
Other Current Assets | 1.3m |
Non-Current Assets | 802k |
PP&E | 631k |
Intangibles | 171k |
Free Cash Flow Analysis
Spectral Medical Inc
CAD | |
Free Cash Flow | CAD |
Earnings Waterfall
Spectral Medical Inc
Revenue
|
2.2m
CAD
|
Cost of Revenue
|
-1.3m
CAD
|
Gross Profit
|
934k
CAD
|
Operating Expenses
|
-15.1m
CAD
|
Operating Income
|
-14.2m
CAD
|
Other Expenses
|
-9.7m
CAD
|
Net Income
|
-23.8m
CAD
|
EDT Profitability Score
Profitability Due Diligence
Spectral Medical Inc's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Score
Spectral Medical Inc's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
EDT Solvency Score
Solvency Due Diligence
Spectral Medical Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Score
Spectral Medical Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EDT Price Targets Summary
Spectral Medical Inc
According to Wall Street analysts, the average 1-year price target for
EDT
is 2.75 CAD
with a low forecast of 2.73 CAD and a high forecast of 2.84 CAD.
Dividends
Current shareholder yield for EDT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EDT
stock under the Base Case scenario is
0.04
CAD.
Compared to the current market price of 1.1 CAD,
Spectral Medical Inc
is
Overvalued by 96%.